<expression xsi:schemaLocation="http://www.imsglobal.org/xsd/imslorsltitm_v1p0 http://fire.eun.org/lode/imslorsltitm_v1p0.xsd" xmlns="http://www.imsglobal.org/xsd/imslorsltitm_v1p0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <identifier>
    <catalog>hdl</catalog>
    <entry>10494/167351</entry>
  </identifier>
  <identifier>
    <catalog>expression-cmr-id</catalog>
    <entry>167351</entry>
  </identifier>
  <description>
    <facet>
      <vocabularyID>LRE.expressionDescriptionFacetValues</vocabularyID>
      <value>main</value>
    </facet>
    <metadata>
      <schema>http://ltsc.ieee.org/xsd/LOM</schema>
      <lom xsi:schemaLocation="http://ltsc.ieee.org/xsd/LOM http://ltsc.ieee.org/xsd/lomv1.0/lomLoose.xsd" xmlns="http://ltsc.ieee.org/xsd/LOM">
        <general>
          <identifier>
            <catalog>oai</catalog>
            <entry>oai:melt.cup.cam.ac.uk:cahi1:data_78791</entry>
          </identifier>
          <identifier>
            <catalog>lre</catalog>
            <entry>cahi1:data_78791</entry>
          </identifier>
          <title>
            <string language="en">Common structural feature in aspirin, 2-hydroxybenzoic acid and salicin</string>
            <string language="x-mt-de">Geläufiges strukturelles Merkmal im aspirin, in 
der Säure 2-hydroxybenzoic und im salicin</string>
            <string language="x-mt-fr">Dispositif structural commun dans l'aspirin, 
l'acide 2-hydroxybenzoic et le salicin</string>
            <string language="x-mt-pt">Característica estrutural comum no aspirin, no 
ácido 2-hydroxybenzoic e no salicin</string>
            <string language="x-mt-it">Caratteristica strutturale comune in aspirin, in 
acido 2-hydroxybenzoic ed in salicin</string>
            <string language="x-mt-el">Κοινό δομικό χαρακτηριστικό γνώρισμα στο aspirin, 
το 2-χυδροξυψενζοηθ οξύ και το salicin</string>
            <string language="x-mt-es">Característica estructural común en aspirin, el
ácido 2-hydroxybenzoic y el salicin</string>
          </title>
          <description>
            <string language="en">This illustration shows the common structural feature, shaded blue, in the structures of aspirin, 2-hydroxybenzoic acid and salicin. This explains the similar pharmacological activity these drugs have in the body.</string>
          </description>
          <language>x-none</language>
          <keyword>
            <string language="en">2-hydroxybenzoic acid</string>
          </keyword>
          <keyword>
            <string language="en">aspirin</string>
          </keyword>
          <keyword>
            <string language="en">fever</string>
          </keyword>
          <keyword>
            <string language="en">pain killers</string>
          </keyword>
          <keyword>
            <string language="en">pharmacological activity</string>
          </keyword>
          <keyword>
            <string language="en">pharmacophore</string>
          </keyword>
          <keyword>
            <string language="en">salicin</string>
          </keyword>
          <keyword>
            <string language="en">salicylic acid</string>
          </keyword>
          <keyword>
            <string language="en">structural feature</string>
          </keyword>
          <structure>
            <source>structureValues</source>
            <value>atomic</value>
          </structure>
          <description>
            <string language="x-mt-de">Diese Abbildung zeigt das geläufige strukturelle 
Merkmal, das schattierte Blau, in den Strukturen von aspirin, die 
Säure 2-hydroxybenzoic und das salicin. Dieses erklärt die 
ähnliche pharmakologische Aktivität, die diese Drogen im Körper 
haben.</string>
          </description>
          <description>
            <string language="x-mt-fr">Cette illustration montre le dispositif 
structural commun, le bleu ombragé, dans les structures de l'aspirin,
l'acide 2-hydroxybenzoic et le salicin. Ceci explique 
l'activité pharmacologique semblable que ces drogues ont dans le 
corps.</string>
          </description>
          <description>
            <string language="x-mt-pt">Esta ilustração mostra a característica 
estrutural comum, o azul protegido, nas estruturas do aspirin, o 
ácido 2-hydroxybenzoic e o salicin. Isto explica a atividade 
que pharmacological similar estas drogas têm no corpo.</string>
          </description>
          <description>
            <string language="x-mt-it">Questa illustrazione mostra la caratteristica 
strutturale comune, l'azzurro protetto, nelle strutture del aspirin, 
l'acido 2-hydroxybenzoic ed il salicin. Ciò spiega l'attività 
che farmacologica analoga queste droghe hanno nel corpo.</string>
          </description>
          <description>
            <string language="x-mt-el">Αυτή η απεικόνιση εμφανίζει το κοινό δομικό 
χαρακτηριστικό γνώρισμα, το σκιασμένο μπλε, στις δομές του 
aspirin, το 2-χυδροξυψενζοηθ οξύ και salicin. Αυτό 
εξηγεί την παρόμοια φαρμακολογική δραστηριότητα που αυτά τα 
φάρμακα αναπτύσσουν στο σώμα.</string>
          </description>
          <description>
            <string language="x-mt-es">Esta ilustración muestra la característica 
estructural común, el azul sombreado, en las estructuras del aspirin,
el ácido 2-hydroxybenzoic y el salicin. Esto explica la 
actividad farmacológica similar que estas drogas tienen en el cuerpo.</string>
          </description>
          <keyword>
            <string language="x-mt-de">Säure 2-hydroxybenzoic</string>
          </keyword>
          <keyword>
            <string language="x-mt-de">aspirin</string>
          </keyword>
          <keyword>
            <string language="x-mt-de">Fieber</string>
          </keyword>
          <keyword>
            <string language="x-mt-de">Schmerzmörder</string>
          </keyword>
          <keyword>
            <string language="x-mt-de">pharmakologische Aktivität</string>
          </keyword>
          <keyword>
            <string language="x-mt-de">Pharmacophore</string>
          </keyword>
          <keyword>
            <string language="x-mt-de">salicin</string>
          </keyword>
          <keyword>
            <string language="x-mt-de">Salizyl- Säure</string>
          </keyword>
          <keyword>
            <string language="x-mt-de">strukturelles Merkmal</string>
          </keyword>
          <keyword>
            <string language="x-mt-fr">acide 2-hydroxybenzoic</string>
          </keyword>
          <keyword>
            <string language="x-mt-fr">aspirin</string>
          </keyword>
          <keyword>
            <string language="x-mt-fr">fièvre</string>
          </keyword>
          <keyword>
            <string language="x-mt-fr">tueurs de douleur</string>
          </keyword>
          <keyword>
            <string language="x-mt-fr">activité pharmacologique</string>
          </keyword>
          <keyword>
            <string language="x-mt-fr">pharmacophore</string>
          </keyword>
          <keyword>
            <string language="x-mt-fr">salicin</string>
          </keyword>
          <keyword>
            <string language="x-mt-fr">acide salicylique</string>
          </keyword>
          <keyword>
            <string language="x-mt-fr">dispositif structural</string>
          </keyword>
          <keyword>
            <string language="x-mt-pt">ácido 2-hydroxybenzoic</string>
          </keyword>
          <keyword>
            <string language="x-mt-pt">aspirin</string>
          </keyword>
          <keyword>
            <string language="x-mt-pt">febre</string>
          </keyword>
          <keyword>
            <string language="x-mt-pt">assassinos da dor</string>
          </keyword>
          <keyword>
            <string language="x-mt-pt">atividade pharmacological</string>
          </keyword>
          <keyword>
            <string language="x-mt-pt">pharmacophore</string>
          </keyword>
          <keyword>
            <string language="x-mt-pt">salicin</string>
          </keyword>
          <keyword>
            <string language="x-mt-pt">ácido salicylic</string>
          </keyword>
          <keyword>
            <string language="x-mt-pt">característica estrutural</string>
          </keyword>
          <keyword>
            <string language="x-mt-it">acido 2-hydroxybenzoic</string>
          </keyword>
          <keyword>
            <string language="x-mt-it">aspirin</string>
          </keyword>
          <keyword>
            <string language="x-mt-it">febbre</string>
          </keyword>
          <keyword>
            <string language="x-mt-it">assassini di dolore</string>
          </keyword>
          <keyword>
            <string language="x-mt-it">attività farmacologica</string>
          </keyword>
          <keyword>
            <string language="x-mt-it">pharmacophore</string>
          </keyword>
          <keyword>
            <string language="x-mt-it">salicin</string>
          </keyword>
          <keyword>
            <string language="x-mt-it">acido salicilico</string>
          </keyword>
          <keyword>
            <string language="x-mt-it">caratteristica strutturale</string>
          </keyword>
          <keyword>
            <string language="x-mt-el">2-χυδροξυψενζοηθ οξύ</string>
          </keyword>
          <keyword>
            <string language="x-mt-el">aspirin</string>
          </keyword>
          <keyword>
            <string language="x-mt-el">πυρετός</string>
          </keyword>
          <keyword>
            <string language="x-mt-el">δολοφόνοι πόνου</string>
          </keyword>
          <keyword>
            <string language="x-mt-el">φαρμακολογική δραστηριότητα</string>
          </keyword>
          <keyword>
            <string language="x-mt-el">pharmacophore</string>
          </keyword>
          <keyword>
            <string language="x-mt-el">salicin</string>
          </keyword>
          <keyword>
            <string language="x-mt-el">salicylic οξύ</string>
          </keyword>
          <keyword>
            <string language="x-mt-el">δομικό χαρακτηριστικό γνώρισμα</string>
          </keyword>
          <keyword>
            <string language="x-mt-es">ácido 2-hydroxybenzoic</string>
          </keyword>
          <keyword>
            <string language="x-mt-es">aspirin</string>
          </keyword>
          <keyword>
            <string language="x-mt-es">fiebre</string>
          </keyword>
          <keyword>
            <string language="x-mt-es">asesinos del dolor</string>
          </keyword>
          <keyword>
            <string language="x-mt-es">actividad farmacológica</string>
          </keyword>
          <keyword>
            <string language="x-mt-es">pharmacophore</string>
          </keyword>
          <keyword>
            <string language="x-mt-es">salicin</string>
          </keyword>
          <keyword>
            <string language="x-mt-es">ácido salicílico</string>
          </keyword>
          <keyword>
            <string language="x-mt-es">característica estructural</string>
          </keyword>
        </general>
        <lifeCycle>
          <contribute>
            <role>
              <source>roleValues</source>
              <value>author</value>
            </role>
            <entity>BEGIN:VCARD
VERSION:3.0
FN:Cambridge-Hitachi Educational Solutions PLC
N:Cambridge-Hitachi
ADR:University Printing House;Shaftesbury Road;Cambridge;CB2 8BS
END:VCARD</entity>
            <date>
              <dateTime>2007-01-01</dateTime>
            </date>
          </contribute>
        </lifeCycle>
        <metaMetadata>
          <identifier>
            <catalog>oai</catalog>
            <entry>oai:melt.cup.cam.ac.uk:metadata_78791</entry>
          </identifier>
          <identifier>
            <catalog>CupSalMetadata</catalog>
            <entry>metadata_78791</entry>
          </identifier>
          <contribute>
            <date>
              <dateTime>2007-01-01</dateTime>
            </date>
          </contribute>
          <language>en</language>
          <contribute>
            <entity>BEGIN:VCARD
FN:Cambridge-Hitachi Educational Solutions PLC
N:Cambridge-Hitachi Educational Solutions PLC
ORG:Cambridge-Hitachi Educational Solutions PLC
VERSION:3.0
END:VCARD</entity>
            <role>
              <value>provider</value>
              <source>LRE.roleMetaValues</source>
            </role>
            <date>
              <dateTime>2009-04-09T19:12:16.26Z</dateTime>
            </date>
          </contribute>
        </metaMetadata>
        <educational>
          <context>
            <source>LRE.contextValues</source>
            <value>higher education</value>
          </context>
          <typicalAgeRange>
            <string language="x-t-lre">16-19</string>
          </typicalAgeRange>
          <learningResourceType>
            <source>LRE.learningResourceTypeValues</source>
            <value>image</value>
          </learningResourceType>
        </educational>
        <rights>
          <copyrightAndOtherRestrictions>
            <source>copyrightAndOtherRestrictionsValues</source>
            <value>yes</value>
          </copyrightAndOtherRestrictions>
          <cost>
            <source>costValues</source>
            <value>no</value>
          </cost>
          <description>
            <string language="x-t-cc-url">http://creativecommons.org/licenses/by-nc-nd/3.0/</string>
            <string language="x-t-cc">&lt;rdf:RDF xmlns="http://web.resource.org/cc/" xmlns:dc="http://purl.org/dc/elements/1.1/"  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"&gt;
			    &lt;Work rdf:about=""&gt;
			    &lt;license rdf:resource="http://creativecommons.org/licenses/by-nc-nd/3.0/"/&gt;
			    &lt;attributionName&gt;Attribution to be given to the licensor if present, otherwise to the author.&lt;/attributionName&gt;
			    &lt;/Work&gt;
			    &lt;License rdf:about="http://creativecommons.org/licenses/by-nc-nd/3.0/"&gt;
			    &lt;requires rdf:resource="http://web.resource.org/cc/Attribution"/&gt;
			    &lt;requires rdf:resource="http://web.resource.org/cc/Notice"/&gt;
			    &lt;permits rdf:resource="http://web.resource.org/cc/Reproduction"/&gt;
			    &lt;permits rdf:resource="http://web.resource.org/cc/Distribution"/&gt;
			    &lt;prohibits rdf:resource="http://web.resource.org/cc/DerivativeWorks" /&gt;
			    &lt;prohibits rdf:resource="http://web.resource.org/cc/CommercialUse" /&gt;
			    &lt;/License&gt;
			    &lt;/rdf:RDF&gt;</string>
          </description>
        </rights>
        <classification>
          <purpose>
            <source>purposeValues</source>
            <value>discipline</value>
          </purpose>
          <taxonPath>
            <source>
              <string language="x-none">LRE-0001</string>
            </source>
            <taxon>
              <id>928</id>
              <entry>
                <string language="en">organic chemistry</string>
              </entry>
            </taxon>
          </taxonPath>
        </classification>
      </lom>
    </metadata>
  </description>
  <manifestation>
    <identifier>
      <catalog>manifestation-cmr-id</catalog>
      <entry>167351</entry>
    </identifier>
    <name>
      <vocabularyID>LRE.manifestationNameValues</vocabularyID>
      <value>experience</value>
    </name>
    <parameter>
      <vocabularyID>MIME</vocabularyID>
      <value>image/jpeg</value>
    </parameter>
    <item>
      <location>
        <uri>http://melt.cup.cam.ac.uk/DataServlet/78791.jpg</uri>
      </location>
    </item>
  </manifestation>
</expression>
